Announcement on the Resignation of Core Technical Personnel
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
The company confirmed that Ms. Zheng's departure will not impact its ongoing research and development or core technologies, as her responsibilities have been successfully transitioned to the remaining team members. The company expressed gratitude for Ms. Zheng's contributions during her tenure and outlined plans to enhance its research capabilities moving forward.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Beijing Balance Medical Technology Co. Ltd. on 6ix
Earlier from Beijing Balance Medical Technology
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Voluntary Disclosure of the Approval and Registration of Subsidiary’s Collagen Implant Products
- Announcement on the Voluntary Disclosure of ePTFE Pericardial Membrane Product Registration Approval
- Report for Q3 2025
Later from Beijing Balance Medical Technology
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Implementation of Dividend Distribution for 2025
- Scheme for Repurchasing Shares through Call Auction
- Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Limit Concerning Shares Repurchase
- Announcement on Initially Repurchasing the Company's Shares through Call Auction
Follow Beijing Balance Medical Technology into a list and get an email when it puts out news.
Follow Beijing Balance Medical Technology